Cancer clinical trials in the region Normandie

126 currently recruiting clinical trials
Region Normandie

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Lung cancer
#NCT05920356
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic KRAS G12C PDL1 Negative (< 1%) None Systemic Treatment-Naive
Targeted therapy Immunotherapy Chemotherapy Targeted therapy Car-T Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC)
CHU Caen Normandie (Caen), Centre Hospitalier Universitaire de Rouen (Rouen)
Amgen
Phase 3 Lung cancer
#NCT05170204
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced ALK Systemic Treatment-Naive
EGFR Immunotherapy Targeted therapy Immunotherapy Targeted therapy
Centre François Baclesse (Caen )
Hoffmann-La Roche
Phase 3 Lymphoma
#NCT06508658
B cell lymphoma Large B cell lymphoma None CD20 Chemotherapy Monoclonal antibodies
Systemic Treatment-Naive Bispecific T-cell engager antibodies
CHU Caen Normandie (Caen)
Genmab
Phase 3 Lung cancer
#NCT05899608
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Non-squamous NSCLC Metastatic Systemic Treatment-Naive
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen)
Summit Therapeutics